Birchview Capital
ADAG icon

Birchview Capital’s Adagene ADAG Stock Holding History

Birchview Capital’s Portfolio ADAG Stock Details ADAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.38M Buy
430,000
+190,000
+79% +$694K 0.79% 31
2026
Q2 		$1.01M Buy
+240,000
New +$903K 0.47% 44

Other funds holding ADAG

HSG Holding
HSG Holding Na, Hong Kong $1.26B AUM 34.86% 1-Year Est. Return
F.L. Putnam Investment Management
F.L. Putnam Investment Management Lynnfield, Massachusetts $9.33B AUM 30.52% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Moneta Group Investment Advisors
Moneta Group Investment Advisors St Louis, Missouri $16.1B AUM 16.18% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $36.2B AUM 20.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Birchview Capital's ADAG Position: Q3 2026 in Review

Birchview Capital increased its Adagene (ADAG) stake by 79% in Q3 2026, buying an estimated $694K and bringing the position to 430,000 shares worth $1.38M. The position accounts for 0.79% of the portfolio, ranked #31.

Birchview Capital first reported a position in ADAG in Q2 2026 and has held it in 2 quarters since. 24 funds tracked by Wall St. Rank hold ADAG as of Q3 2026.

  • Birchview Capital held 430,000 shares of Adagene worth $1.38M as of Q3 2026.
  • Birchview Capital bought 190,000 Adagene shares in Q3 2026, an estimated $694K.
  • Adagene made up 0.79% of Birchview Capital's portfolio in Q3 2026, its #31 holding.
  • Birchview Capital first reported a position in Adagene in Q2 2026 and has held it in 2 quarters since.
  • 24 funds tracked by Wall St. Rank held Adagene as of Q3 2026.

Based on Birchview Capital's 13F filing for Q3 2026, filed 13 Nov 2026.